In the modern medicine the use of pharmaceutical products for treatment of wide spectrum of diseases is indispensable and of common practice. Hence, the responsibility of the pharmaceutical companies to guarantee the safety of their drugs for human consumption is enormous. Unfortunately, there are cases from the history proving that due to improper testing and human negligence drugs caused more harm than good. Even in the present day, these tragedies are worth an examination in order to remember and learn from past mistakes and to prevent their recurrence. Many people believe that street drugs are “an entirely different class than prescription drugs, and they believe that pharmaceutical companies would never manufacture or sell street drugs”. Actually the well-known pharmaceutical giant, Bayer AG, is responsible for the most addictive and feared drug nowadays – heroin. Exactly 50 years ago, on 1. October 1957, another big pharmaceutical producer, Grünenthal, introduced the substance thalidomide. It was perscribed mainly as a sedative and for treatment of morning sickness during pregnancy, before it was discovered that the drug caused severe birth defects. In this assignment I will investigate the consequences caused by both drugs, as well the role of the producing company in the tragedy. By providing a brief history of the development of heroin and thalidomide, as well as a detailed research of the testing and marketing strategies, I am interested in the crisis management measures that Bayer AG and Chemie Grünenthal applied to handle the catastrophes. Since heroin and Contergan were distributed all over the world, their negative effects caused harm globally. In the conclusion of the assignment, I will give a short analysis of the corporation’s efforts to prevent further damage and to reverse existing problems, bearing in mind the social responsibilities of the pharmaceutical sector.
Table of Contents
1 Introduction
2 Crisis Management at pharmaceutical companies Bay
3 Bayer and the Heroin Crisis
3.1 Brief history of heroin, the new wonder drug
3.2 Advertising and Marketing of Heroin
3.3 Banning Heroin from the Market
3.4 Bayer’s Response to the Crisis
4 Chemie Grünenthal and the Thalidomide Crisis
4.1 Brief History of Grünenthal’s thalidomide
4.2 Research, development, testing and marketing of thalidomide
4.3 The thalidomide tragedy
4.4 Chemie Grunenthal’s actions after the tragedy
4.5 How victims were treated
5 Conclusion
6 References
Objectives and Research Focus
The paper examines the crisis management strategies employed by Bayer AG and Chemie Grünenthal in response to the public health catastrophes caused by heroin and thalidomide. It explores how corporate decision-making and negligence contributed to these crises and investigates the adequacy of the companies' responses regarding their social responsibility.
- Analysis of the historical development and marketing of heroin by Bayer.
- Examination of the thalidomide scandal involving Chemie Grünenthal.
- Evaluation of corporate crisis management and communication strategies.
- Assessment of the role of regulation and state control in preventing medical disasters.
- Discussion on the social and ethical responsibilities of pharmaceutical corporations.
Excerpt from the Book
4.2 Research, development, testing and marketing of thalidomide
Wishing to take a large share of the sedative market, which at that time was dominated by the group of barbiturates, Chemie Grünenthal started a huge advertising campaign for Contergan. The company marketed the drug with advertisements depicting peaceful nature scenes and recommended using thalidomide as a break from stressful work life. Parents even gave it to their children, earning Contergan the nickname “West Germany’s baby-sitter” (Daemmlich, 2002). The company also developed international markets by exporting the drug and selling it under licensing agreements, making it available in over 46 countries.”18
The advertising efforts paid off. In 1959, only two years after bringing thalidomide to the market, the pharmaceutical company was selling daily 1 million pills only in Germany, producing more than one ton a month. The “wonder drug” was sold mostly without a prescription - a favourable circumstance for the vast consumer market. It became even more popular after the British Distillers Ltd. confirmed its safety for pregnant women. The non toxic qualities of the drug were the best argument for its selling and Contergan became a particular economic success. The aggressive advertising program included as target groups, on one side, pregnant women, on the other side, parents of hyperactive and restless children. The drug, sold in many countries worldwide, was so popular that it was produced also as sweet syrup.
Summary of Chapters
1 Introduction: Provides an overview of the pharmaceutical industry's responsibilities and outlines the scope of the study regarding the heroin and thalidomide tragedies.
2 Crisis Management at pharmaceutical companies Bay: Defines the term "crisis" within the pharmaceutical sector and establishes the criteria for evaluating corporate responses to scandals.
3 Bayer and the Heroin Crisis: Details the development, aggressive marketing, and subsequent banning of heroin, highlighting the company's attempts to distance itself from the drug's history.
4 Chemie Grünenthal and the Thalidomide Crisis: Investigates the rapid market expansion of thalidomide, the lack of rigorous safety testing, and the devastating impact of the resulting birth defects.
5 Conclusion: Summarizes the findings on corporate negligence and emphasizes the need for stronger regulatory oversight and ethical pharmaceutical practices.
6 References: Lists the sources and literature used to support the research findings.
Keywords
Heroin, Contergan, Thalidomide, Bayer AG, Chemie Grünenthal, Crisis Management, Pharmaceutical Industry, Medical Negligence, Public Health, Drug Testing, Corporate Social Responsibility, Teratogenic, Birth Defects, Marketing Strategies, Regulatory Oversight.
Frequently Asked Questions
What is the core focus of this assignment?
This work explores the historical cases of heroin and thalidomide as examples of pharmaceutical crisis management and the consequences of corporate negligence regarding drug safety.
Which companies and drugs are central to this study?
The study centers on Bayer AG and its role in the development and marketing of heroin, as well as Chemie Grünenthal and its involvement in the thalidomide tragedy.
What is the primary objective of this research?
The research aims to evaluate whether the crisis management measures taken by these companies were appropriate and effective, given their social responsibilities.
Which scientific or analytical method is applied?
The author uses a historical and descriptive analysis of company policies, marketing strategies, and the legal outcomes of both crisis events to assess corporate accountability.
What topics are covered in the main section?
The main sections cover the development history of the drugs, the aggressive marketing techniques employed, the discovery of side effects, and the subsequent legal and social responses.
Which terms best characterize this work?
Key concepts include corporate social responsibility, pharmaceutical ethics, crisis communication, and the impact of regulatory frameworks on drug safety.
How did Bayer respond to the heroin crisis historically?
Bayer initially promoted heroin as a non-addictive "wonder drug" and, after being forced to stop production, eventually attempted to erase the history of its invention from official company records.
What was the outcome of the legal proceedings regarding the thalidomide tragedy?
The "Contergan Trial" ended without a guilty verdict for the company's managers, resulting instead in an out-of-court agreement for the financial recompensation of victims.
- Quote paper
- Margarita Russeva (Author), 2007, Heroin and Contergan, Munich, GRIN Verlag, https://www.grin.com/document/117487
